The current status of CLL treatment and how clinical practice will change
What is the role of inotuzumab ozogamicin in ALL
Results of the German acute myeloid leukemia (AML) intergroup study
How can MRD and disease be assessed in routine practice?
MPN Landmark studies: looking at the disparities in perceptions of disease and treatment preferences